Acrocyanosis and digital necrosis are associated with poor prognosis in COVID-19

Guitti Pourdowlat1, Zohre Naderi2, Farhad Seif3,4

  • 1Chronic Respiratory Diseases Research Center National Research Institute of Tuberculosis and Lung Diseases Shahid Beheshti University of Medical Sciences Tehran Iran.

Clinical Case Reports
|December 28, 2020
PubMed

Insights

Acrocyanosis and digital necrosis in COVID-19 patients indicate microvascular issues and may predict outcomes. This microangiopathic and immunothrombosis phenomenon suggests broader organ involvement, impacting prognosis.

Area of Science:

  • Vascular Medicine
  • Immunology
  • Infectious Diseases

Background:

  • Microvascular dysfunction is increasingly recognized in severe infections.
  • Immunothrombosis plays a critical role in the pathophysiology of various diseases.

Observation:

  • Acrocyanosis and digital necrosis were observed in patients.
  • These findings are linked to microangiopathic and immunothrombosis phenomena.

Findings:

  • Microvascular involvement in acrocyanosis and digital necrosis can extend to other organs.
  • This microvascular complication has prognostic significance in COVID-19.

Implications:

  • Monitoring for peripheral vascular complications may aid in predicting COVID-19 severity.
  • Understanding immunothrombosis in COVID-19 is crucial for developing targeted therapies.

Related Concept Videos

Cardiovascular System Abnormal Findings I: Inspection and Palpation01:29

Cardiovascular System Abnormal Findings I: Inspection and Palpation

In a cardiovascular examination, inspection and palpation are crucial for identifying abnormalities.
Abnormal findings observed during an inspection
665
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
177
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
141
Acute Respiratory Failure-IV01:23

Acute Respiratory Failure-IV

Respiratory failure can manifest suddenly or gradually, characterized by a rapid decline in PaO2 and a rapid rise in PaCO2. This situation indicates a severe respiratory problem that may quickly become a life-threatening emergency. One of the early signs of hypoxemic Acute Respiratory Failure (ARF) is a change in mental status due to the brain's sensitivity to oxygen levels and changes in acid-base balance. Symptoms such as restlessness, confusion, and agitation suggest inadequate oxygen...
366
Pneumothorax-I01:26

Pneumothorax-I

A pneumothorax is a condition where air builds up in the space between the lung and the chest wall, causing the lung to collapse. This condition arises when air enters the space between the parietal and visceral pleura, disrupting the negative pressure essential for lung inflation. This can lead to a partial or complete collapse of the lung.
Pneumothorax can be even further classified as spontaneous, traumatic, and tension pneumothorax.
792
Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
529